IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional images of lumen, it does not allow complete visualization of vascular structures. This can hinder appropriate selection of device size, balloon or stent, as well as the accurate assessment of procedural outcomes.

Intravascular ultrasound (IVUS) provides detailed information on vessel dimension and plaque characteristics. Its use has been shown to improve clinical outcomes in the treatment of complex coronary lesions. In recent years, IVUS has been increasingly used in peripheral artery disease; however, supporting clinical evidence vs standard angiography in peripheral artery interventions remains limited.

This prospective, multicenter, randomized study aimed to evaluate the outcomes of IVUS-guided vs angiography-guided treatment of femoropopliteal lesions with different levels of lesion complexity.

The primary endpoint was target lesion primary patency, defined as absence of clinically driven target lesion revascularization (CD-TLR) or restenosis at 12 months. The secondary endpoint included CD-TLR as well as clinical and hemodynamic improvement parameters.

A total of 237 patients undergoing drug-coated balloon angioplasty for femoropopliteal lesions were included in the IVUS-DCB study; 158 had complex lesions (TASC II type C/D) and 79 had non-complex lesions (TASC II type A/B).

Read also: QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis.

In complex lesions, IVUS use was associated with significantly higher primary patency (82.1% vs. 60.3%; HR: 0.34; 95% CI: 0.16-0.70; p = 0.002), lower incidence of CD-TLR (90.0% vs. 76.9%; HR: 0.31; 95% CI: 0.13-0.75; p = 0.01), and sustained clinical and hemodynamic improvement vs angiography guided angioplasty.

As regards non-complex lesions, no significant differences were observed in primary patency (87.5% vs. 88.2%; HR: 1.84; 95% CI: 0.39-8.60; p = 0.44) or incidence of secondary evaluation criteria between IVUS and angiography-guided balloon angioplasty.

Conclusion

 IVUS-guided drug coated balloon angioplasty was associated with higher primary patency rate and clinical improvement vs. the angiography-guided in the treatment of complex femoropopliteal lesions. In contrast, non-complex lesions showed no significant differences between these methods. 

Original Title: Intravascular Ultrasound-Guided vs Angiography-Guided Drug-Coated Balloon Angioplasty in Patients With Complex Femoropopliteal Artery Disease.

Reference: Seung-Jun Lee, MD et al JACC Cardiovasc Interv. 2025;18:558–569.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

Más artículos de este Autor

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas Panamá 2026
Jornadas SOLACIspot_img

Artículos recientes

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Fellow’s Corner – Case 1: Chronic Total Occlusion Treated via Retrograde Approach. A True Challenge

Share your experience. Learn from experts. Grow as an interventionalist. We present the first case of this new edition of The Fellow’s Corner, an academic...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...